Impaired mixed leucocyte reaction in some different diseases, notably multiple sclerosis and various arthritides
Hedberg, H.; Källén, B.; Löw, B.; Nilsson, O.
Clinical and Experimental Immunology 9(2): 201-207
1971
ISSN/ISBN: 0009-9104 PMID: 5570678 Document Number: 40886
Document emailed within 1 workday
Related Documents
Hanby-Flarida, M.D.; Okragly, A.J.; Baldwin, C.L. 1996: Autologous mixed leucocyte reaction and the polyclonal activation of bovine gamma/delta T cells Research in veterinary science 61(1): 65-71Lahat, N.; Zelnik, N.; Froom, P.; Kinarty, A.; Etzioni, A. 1988: Impaired autologous mixed lymphocyte reaction (AMLR) in patients with ataxia-telangiectasia and their family members Clinical and Experimental Immunology 74(1): 32-35
Tombul, T.; Anlar, O.; Tuncer, M.; Huseyinoglu, N.; Eryonucu, B. 2011: Impaired heart rate variability as a marker of cardiovascular autonomic dysfunction in multiple sclerosis Acta Neurologica Belgica 111(2): 116-120
Feys, P.; Bibby, B.M.; Baert, I.; Dalgas, U. 2015: Walking capacity and ability are more impaired in progressive compared to relapsing type of multiple sclerosis European Journal of Physical and Rehabilitation Medicine 51(2): 207-210
Rogozea, R.; Florea-Ciocoiu, V. 1988: Retention of orienting reaction habituation in multiple sclerosis Neurologie et Psychiatrie 26(4): 223-235
Arena, R.; Mazzoni, M.; Moretti, P.; Lepori, P.; Giraldi, C.; Muratorio, A. 1986: Reaction times to lateralized visual stimuli in multiple sclerosis Acta Neurologica 8(5): 545-553
Dantas, R.O.; Villanova, M.G.; de Godoy, R.A. 1985: Esophageal dysfunction in patients with progressive systemic sclerosis and mixed connective tissue diseases Arquivos de Gastroenterologia 22(3): 122-126
Schanke, A.K.; Grimsmo, J.; Sundet, K. 1995: Multiple sclerosis and prerequisites for driver's licence. A retrospective study of 33 patients with multiple sclerosis assessed at Sunnaas hospital Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(11): 1349-1352
Bykova, O.V.; Nankina, I.A.; Platonova, A.N.; Karpacheva, N.G.; Petrova, O.A.; Gorina, T.P.; Batysheva, T.T.; Serkov, S.V.; Kuzenkova, L.M. 2013: Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(10 Pt 2): 61-68
Laosanguanek, N.; Wiroteurairuang, T.; Siritho, S.; Prayoonwiwat, N. 2011: Reliability of the Thai version of SF-36 questionnaire for an evaluation of quality of life in multiple sclerosis patients in multiple sclerosis clinic at Siriraj Hospital Journal of the Medical Association of Thailand 94 Suppl. 1: S84-S88
Alvarez, R.; Cour, I.; Kanaan, A.; Benedicto, M.; Martín-Estefanía, C.; Arroyo, R.; Varela de Seijas, E.; Picazo, J.J. 2000: Detection of viral genomes of the Herpesviridae family in multiple sclerosis patients by means of the polymerase chain reaction (PCR) Enfermedades Infecciosas y Microbiologia Clinica 18(5): 223-228
Reclos, G.J.; Baxevanis, C.N.; Sfagos, C.; Papageorgiou, C.; Tsokos, G.C.; Papamichail, M. 1987: Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis Clinical and Experimental Immunology 70(2): 336-344
Steerman, R.L.; Snyderman, R.; Leikin, S.L.; Colten, H.R. 1971: Instrinsic defect of the polymorphonuclear leucocyte resulting in impaired chemotaxis and phagocytosis Clinical and Experimental Immunology 9(6): 939-946
Saida, T. 2004: Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis Rinsho Shinkeigaku 44(11): 796-798
Kira, J-Ichi. 2010: Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases Rinsho Shinkeigaku 50(11): 788-793
Neu, I.; Begemann, H. 1974: Concomitant diseases in multiple sclerosis from the viewpoints of internal medicine and neurology. (I) Münchener Medizinische Wochenschrift 116(16): 833-836
Bizouard, P.; Guisard, D.; André, J.M.; Arnould, G. 1970: The C.S.F. protein formula in central nervous system diseases and especially in multiple sclerosis. Study of 218 examinations La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 46(31): 2151-2162
Shons, A.R.; Etheredge, E.E.; Najarian, J.S. 1972: Variables in the quantitation of the mixed leucocyte response by tritiated thymidine uptake Clinical and Experimental Immunology 12(3): 351-356
Tournier-Lasserve, E.; Lyoncaen, O.; Roullet, E.; Bach, M.A. 1987: IL-2 receptor and HLA class Ii antigens on cerebrospinal fluid cells of patients with multiple sclerosis and other neurological diseases Clinical and Experimental Immunology 67(3): 581-586
Schulz, L.C. 1981: Infectious arthritides. Animal diseases as models of bacterial and viral etiology Münchener Medizinische Wochenschrift 123(49): 1881-1884